Literature DB >> 14969651

Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men.

Wael K Al-Delaimy1, Anwar T Merchant, Eric B Rimm, Walter C Willett, Meir J Stampfer, Frank B Hu.   

Abstract

PURPOSE: To assess the relation between the duration of diabetes and the risk of peripheral arterial disease among men.
METHODS: A total of 48,607 men in the Health Professionals Follow-up Study who returned a questionnaire in 1986 were followed for 12 years. Peripheral arterial disease (intermittent claudication or surgery for peripheral arterial diseases in the lower extremities) was ascertained by biennial questionnaire and confirmed by medical record review. Diabetes status and other cardiovascular risk factors were also ascertained by biennial questionnaire.
RESULTS: During follow-up (534,588 person-years), we documented 387 cases of peripheral arterial disease. After adjusting for cardiovascular risk factors, the relative risk of developing peripheral arterial disease among men with diabetes compared with men without diabetes was 2.61 (95% confidence interval [CI]: 1.98 to 3.45). Compared with men without diabetes, the relative risk of peripheral arterial disease among men with diabetes increased with duration of disease, even after adjusting for cardiovascular risk factors: 1.39 (95% CI: 0.82 to 2.36) for 1 to 5 years of diabetes, 3.63 (95% CI: 2.23 to 5.88) for 6 to 10 years, 2.55 (95% CI: 1.50 to 4.32) for 11 to 25 years, and 4.53 (95% CI: 2.39 to 8.58) for >25 years of diabetes (P for trend < or =0.0001).
CONCLUSION: These results indicate that duration of type 2 diabetes is associated strongly with the risk of developing peripheral arterial disease.

Entities:  

Mesh:

Year:  2004        PMID: 14969651     DOI: 10.1016/j.amjmed.2003.09.038

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

2.  Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.

Authors:  Kazuhide Ishikura; Hirofumi Misu; Masafumi Kumazaki; Hiroaki Takayama; Naoto Matsuzawa-Nagata; Natsumi Tajima; Keita Chikamoto; Fei Lan; Hitoshi Ando; Tsuguhito Ota; Masaru Sakurai; Yumie Takeshita; Kenichiro Kato; Akio Fujimura; Ken-Ichi Miyamoto; Yoshiro Saito; Satomi Kameo; Yasuo Okamoto; Yoh Takuwa; Kazuhiko Takahashi; Hiroyasu Kidoya; Nobuyuki Takakura; Shuichi Kaneko; Toshinari Takamura
Journal:  Diabetologia       Date:  2014-07-03       Impact factor: 10.122

3.  Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes.

Authors:  Moatasem Salah Amer; Omar Hussien Omar; Randa Abdel Wahab Reda; Tomader Taha Abdel Rahman; Doha Rasheedy
Journal:  Int J Angiol       Date:  2015-06

4.  Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.

Authors:  Bradley S Miller; Shoshana R Blumenthal; Alexey Shalygin; Kevin D Wright; Alexander Staruschenko; John D Imig; Andrey Sorokin
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

5.  [Chronic leg ulcers in older patients].

Authors:  N Duschek; F Trautinger
Journal:  Z Gerontol Geriatr       Date:  2019-06-11       Impact factor: 1.281

Review 6.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 7.  Vascular disease in the lower limb in type 1 diabetes.

Authors:  Michael Edmonds
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

8.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Authors:  Michel M Joosten; Jennifer K Pai; Monica L Bertoia; Eric B Rimm; Donna Spiegelman; Murray A Mittleman; Kenneth J Mukamal
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

9.  A supercritical fluid chromatography/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma.

Authors:  Y K Agrawal; P J Gogoi; K Manna; H G Bhatt; V K Jain
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

10.  High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

Authors:  Federico Biscetti; Giuseppe Straface; Raimondo De Cristofaro; Stefano Lancellotti; Paola Rizzo; Vincenzo Arena; Egidio Stigliano; Giovanni Pecorini; Kensuke Egashira; Giulia De Angelis; Giovanni Ghirlanda; Andrea Flex
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.